Barclays raised the firm’s price target on RenaissanceRe (RNR) to $341 from $310 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- RenaissanceRe price target raised to $327 from $323 at Keefe Bruyette
- RenaissanceRe price target raised to $290 from $280 at TD Cowen
- RenaissanceRe downgraded to Equal Weight from Overweight at Morgan Stanley
- RenaissanceRe price target raised to $333 from $328 at Citi
- RenaissanceRe raises quarterly dividend, renews share repurchase program